Prelude Therapeutics INC (PRLD) — DEF 14A Filings

All DEF 14A filings from Prelude Therapeutics INC. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Prelude Therapeutics Files 2025 Proxy Statement — Apr 29, 2025 Risk: low
Prelude Therapeutics Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting on June 12, 2025. The company, incorporated in Delaware
Prelude Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders — Apr 26, 2024 Risk:
Prelude Therapeutics Inc (PRLD) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual Meeting of Stockholders for Prelude Therapeuti

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX